In addition, elevated expression of Ets1 and Ets2 identified in invasive breast cancers has been correlated with increased expression of the p160 nuclear receptor coactivators NCOA1 (SRC1) and NCOA3 (AIB/SRC3) [5]. The gene discussed is NCOA3; the disease is invasive breast carcinoma.